Publication dates

All regions

Rheumatoid Arthritis Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Therapeutics, Disease Testing, more »


 
1-20 of about 8 900 reports for Rheumatoid Arthritis

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Dermatitis, skin papillomas, and rheumatoid arthritis. It's biologic products technology platform is used for the development of products. The company's initial product cand is psoraxine which is used ...

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Infectious formula with anti mersa capabilities, rheumatoid arthritis, refractory tumors and diabetes products. The company offers treatment in the therapeutic areas, such as dermatology, sexual health and performance ...

MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Inflammatory and anti-infective properties. Its mp1032 is used in the treatment of rheumatoid arthritis, inflammatory bowel disease, copd, local and generalized bacterial infections and viral infections. Metrio ...

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Such as fatigue and appetite loss, anemia, colorectal cancer, liver cancer, rheumatoid arthritis and hepatitis c, among others. The company has collaboration with multinational pharmaceutical or biotech companies ...

Conpharm AB (CONP B) - Financial and Strategic SWOT Analysis Review

Conpharm AB (CONP B) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... On substances extracted from the podophyllum plant worldwide. Its sectors include podophyllum emodi, wartec and condyloma, and reumacon and rheumatoid arthritis. Conpharm's product wartec is used ...

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... To prevent bone and joint diseases and conditions, such as osteoporosis, osteoarthritis, and rheumatoid arthritis. Its projects include capthymone, capsitonin, tnf regularors bn006 and bone cell regulators bn ...

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Of rheumatoid arthritis, glaucoma and psoriasis. Its cf 102, is an oral drug used to treat liver cancer and cf 602, is an allosteric modulator used in the treatment of inflammatory diseases. The company conducts ...

Cellceutix Corporation (Symbol:CTIX) SWOT Analysis, Strategy, Revenues and Profits

Cellceutix Corporation (Symbol:CTIX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Multiple tumors, cand targeting psoriasis, cand targeting rheumatoid arthritis, cand with potential for indications of osteo-arthritis or asthma, and others. It provides services in the areas ...

Galapagos NV (Symbol:GLPGA) SWOT Analysis, Strategy, Revenues and Profits

Galapagos NV (Symbol:GLPGA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Glpg0778/555 is used for the treatment of immuno and inflammatory diseases. Galapagos's glpg0634 is an orally-available, selective inhibitor of jak1 used for the treatment of rheumatoid arthritis ...

GenoMed, Inc. - Strategic SWOT Analysis Review

GenoMed, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Syndrome, lupus, rheumatoid arthritis and alzheimer's disease. Genomed is headquartered in leesburg, florida, the us.This comprehensive swot profile of genomed, inc. Provides you with an in ...

About 1 100 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Astellas Annual Report 2013

  • Annual Report 2013
  • January 2013
    142 pages
  • Drug  

  • Japan  

    World  

    Asia  

View report >

1 Companies for Rheumatoid Arthritis

Read our Company Profiles

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.